Damas Matiko Nyang’anyi  is a Manager for Clinical Trials Control and  Pharmacovigilance at The Tanzania Medicines and Medical Devices Authority (TMDA). His experience as regulatory expert spans over 19 years, of which 15 years at senior managerial level. He is a pharmacist by Profession and in that capacity, he brings in with him a vast hand-on experience in the field of Pharmacovigilance and Clinical trials in resource limited settings like Tanzania. Both Pharmacovigilance and Clinical trials  Functions at TMDA are all WHO- Maturity Level -3. By 31^st May, 2024; TMDA had surpassed WHO national annual  targets for the number of adverse drug reactions (ADRs) reports and  adverse events following immunizations (AEFI)reports. His endeavours and supervisory role in this milestone achievement are highly commended.  He serves a secretariat to the National Vigilance Technical Committee in his home country.